Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. EHC
EHC logo

EHC Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
106.710
Open
106.710
VWAP
104.74
Vol
394.97K
Mkt Cap
10.63B
Low
103.400
Amount
41.37M
EV/EBITDA(TTM)
10.02
Total Shares
99.42M
EV
13.84B
EV/OCF(TTM)
11.76
P/S(TTM)
1.84
Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. It operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. It operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. It provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.
Show More

Events Timeline

(ET)
2026-02-13
08:10:00
Encompass Health to Build 50-Bed Rehab Hospital in Mississippi
select
2026-02-12 (ET)
2026-02-12
09:30:00
Enhabit and Encompass Health Awarded $43.1M
select
2026-02-05 (ET)
2026-02-05
20:00:00
Amazon Falls Over 10% After Earnings Report
select
2026-02-05
16:40:00
Sees FY26 Revenue at $6.365B-$6.465B
select
2026-02-05
16:30:00
Company Reports Q4 Revenue of $1.54B
select
2025-12-02 (ET)
2025-12-02
21:30:00
Bitcoin Rebounds Supporting Market Stabilization; Multiple Companies Release Earnings
select
2025-12-02
12:11:00
Banco Santander Sells 3.5% Stake in Santander Bank Polska for $473.1M
select
link
2025-12-01 (ET)
2025-12-01
16:40:00
Encompass Health Affirms FY25 Revenue Guidance of $5.905B-$5.955B
select
2025-11-25 (ET)
2025-11-25
08:19:33
Encompass Health and Vanderbilt Health to Construct 40-Bed Rehab Facility
select

News

moomoo
8.5
03-10moomoo
PinnedEncompass Health Corp Secures $1 Billion Revolving Credit Facility with $260 Million Letter of Credit Subfacility in 2026 Credit Agreement - SEC Filing
  • Credit Agreement Overview: Compass Health Corp has secured a $1 billion revolving credit facility to enhance its financial flexibility.

  • Additional Credit Facility: The agreement includes a $260 million letter of credit sub-facility, providing further support for operational needs.

moomoo
8.5
03-10moomoo
ENCOMPASS HEALTH CORP - DISCONTINUES 2022 CREDIT AGREEMENT AND SETTLES OUTSTANDING BALANCES - SEC FILING
  • Credit Agreement Termination: Compass Health Corp has terminated its 2022 credit agreement, signaling a significant financial decision.

  • Outstanding Amounts Paid Off: The company has successfully paid off outstanding amounts, indicating improved financial stability.

Newsfilter
8.5
03-03Newsfilter
Encompass Health Opens New Rehabilitation Hospital in South Carolina
  • New Hospital Opening: Encompass Health has opened a 49-bed rehabilitation hospital in Irmo, South Carolina, now accepting patients and aiming to provide essential rehabilitation services for stroke, brain injury, and other patients to enhance their quality of life.
  • Therapeutic Services: The hospital offers a minimum of 15 hours of intensive physical, occupational, and speech therapy weekly, combined with frequent physician visits and 24-hour nursing care, ensuring comprehensive support for patients during their recovery process to accelerate healing.
  • Facility Design: The hospital features 49 private patient rooms, a spacious therapy gym, and activities of daily living simulation spaces equipped with advanced rehabilitation technologies, designed to meet diverse patient needs and improve recovery outcomes.
  • Regional Impact: This marks Encompass Health's 11th location in South Carolina, highlighting the company's ongoing expansion in the region, which is expected to provide more accessible rehabilitation services to the local community and enhance the company's market competitiveness.
PRnewswire
1.0
02-26PRnewswire
Encompass Health to Participate in Barclays Global Healthcare Conference
  • Conference Participation: Encompass Health will participate in the Barclays Global Healthcare Conference from March 10-12, 2026, with President and CEO Mark Tarr and CFO Doug Coltharp scheduled for a 25-minute fireside chat on March 11, which is expected to attract investor attention and enhance the company's visibility in the healthcare sector.
  • Live Broadcast: The fireside chat will be broadcast live on Encompass Health's investor website, ensuring that a wide range of investors can access the latest company updates in real-time, thereby enhancing transparency and fostering investor engagement.
  • Company Background: Encompass Health is the largest operator of inpatient rehabilitation hospitals in the U.S., with 173 hospitals across 39 states and Puerto Rico, dedicated to providing high-quality rehabilitative care for patients recovering from major injuries or illnesses, utilizing advanced technology and innovative treatments to maximize recovery outcomes.
  • Industry Recognition: The company is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista, and is ranked among Fortune's World's Most Admired Companies and Forbes' America's Best Companies, demonstrating its strong competitive position and excellent reputation in the industry.
PRnewswire
8.5
02-24PRnewswire
Encompass Health Earns Two Prestigious Honors
  • Six Consecutive Years of Recognition: Encompass Health has been named to the Fortune 2026 World's Most Admired Companies list for the sixth consecutive year, highlighting its excellence in patient care and corporate culture, thereby solidifying its reputation in the industry.
  • Industry Acknowledgment: The company was also included in Forbes' 2026 America's Best Companies list, indicating its outstanding performance across multiple dimensions such as customer satisfaction, financial performance, and leadership consistency, which enhances investor confidence.
  • National Coverage: Encompass Health operates 173 hospitals across 39 states and Puerto Rico, dedicated to providing high-quality rehabilitative care for patients recovering from major injuries or illnesses, utilizing advanced technology and innovative treatments to maximize recovery outcomes.
  • Commitment to the Future: CEO Mark Tarr stated that these honors reflect the exceptional work of clinicians and the trust earned from patients, and the company is committed to helping more communities regain independence, showcasing its strategic vision for long-term growth.
Newsfilter
8.5
02-24Newsfilter
Encompass Health Recognized in Fortune and Forbes Lists
  • Sixth Consecutive Year: Encompass Health has been named to the Fortune 2026 World's Most Admired Companies list for the sixth consecutive year, highlighting its excellence in patient care, corporate culture, and long-term performance, thereby reinforcing its reputation in the industry.
  • Industry Leadership: The company operates 173 hospitals across 39 states and Puerto Rico, utilizing advanced technology and innovative treatment methods to provide high-quality rehabilitative care, ensuring its leadership position in the inpatient rehabilitation sector.
  • Comprehensive Evaluation: The inclusion in Forbes' 2026 America's Best Companies list is based on a broad evaluation of thousands of companies, covering metrics such as customer satisfaction, financial performance, and workplace culture, demonstrating the company's outstanding performance across various dimensions.
  • Commitment to Future Growth: CEO Mark Tarr stated that these recognitions reflect the exceptional work of clinicians and the trust earned from patients, emphasizing the company's commitment to helping individuals regain independence and its strategic vision for future community expansion.
Wall Street analysts forecast EHC stock price to rise
5 Analyst Rating
Wall Street analysts forecast EHC stock price to rise
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
134.00
Averages
146.75
High
160.00
Current: 0.000
sliders
Low
134.00
Averages
146.75
High
160.00
Barclays
NULL -> Overweight
maintain
$150 -> $153
AI Analysis
2026-02-06
Reason
Barclays
Price Target
$150 -> $153
AI Analysis
2026-02-06
maintain
NULL -> Overweight
Reason
Barclays raised the firm's price target on Encompass Health to $153 from $150 and keeps an Overweight rating on the shares. The firm updated the company's model post the Q4 report.
Barclays
Andrew Mok
Overweight
maintain
$141 -> $150
2025-10-30
Reason
Barclays
Andrew Mok
Price Target
$141 -> $150
2025-10-30
maintain
Overweight
Reason
Barclays analyst Andrew Mok raised the firm's price target on Encompass Health to $150 from $141 and keeps an Overweight rating on the shares. The company reported a modest Q4 beat, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for EHC
Unlock Now

Valuation Metrics

The current forward P/E ratio for Encompass Health Corp (EHC.N) is 18.83, compared to its 5-year average forward P/E of 19.41. For a more detailed relative valuation and DCF analysis to assess Encompass Health Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
19.41
Current PE
18.83
Overvalued PE
21.47
Undervalued PE
17.35

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
11.03
Current EV/EBITDA
10.69
Overvalued EV/EBITDA
11.87
Undervalued EV/EBITDA
10.20

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.49
Current PS
1.70
Overvalued PS
1.74
Undervalued PS
1.24

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what other stocks should I buy and why
Intellectia · 14 candidates
Market Cap: >= 10.00BAnalyst Consensus: Strong Buy, Moderate BuyEps 5yr Cagr: >= 10Pe Ttm: 10 - 35Target Price Upside Potential: MoreAbovePriceOne Month Predict Return: >= 0.0%
Ticker
Name
Market Cap$
top bottom
PTC logo
PTC
PTC Inc
19.39B
MSFT logo
MSFT
Microsoft Corp
3.01T
NVO logo
NVO
Novo Nordisk A/S
171.90B
SEIC logo
SEIC
SEI Investments Co
10.00B
BMRN logo
BMRN
BioMarin Pharmaceutical Inc
11.62B
BR logo
BR
Broadridge Financial Solutions Inc
22.04B
what are the best stocks to buy today
Intellectia · 16 candidates
Market Cap: >= 10.00BRegion: USAnalyst Consensus: Strong Buy, Moderate BuyList Exchange: XNYS, XNAS, XASETarget Price Upside Potential: MoreAbovePriceMoving Average Relationship: PriceAboveMA20
Ticker
Name
Market Cap$
top bottom
NVDA logo
NVDA
NVIDIA Corp
4.65T
PDD logo
PDD
PDD Holdings Inc
150.14B
QCOM logo
QCOM
Qualcomm Inc
149.82B
SMFG logo
SMFG
Sumitomo Mitsui Financial Group, Inc
148.10B
SNY logo
SNY
Sanofi SA
114.04B
CEG logo
CEG
Constellation Energy Corp
106.46B
what stock to buy Monday
Intellectia · 5 candidates
Market Cap: >= 10.00BBeta: LowRisk, ModerateRiskWeekly Average Turnover: >= 1,000,000Rsi 14: <= 35Week Price Change Pct: >= $-1.00
Ticker
Name
Market Cap$
top bottom
ET logo
ET
Energy Transfer LP
60.60B
MPLX logo
MPLX
MPLX LP
56.57B
PAA logo
PAA
Plains All American Pipeline LP
13.48B
YMM logo
YMM
Full Truck Alliance Co Ltd
10.30B
EHC logo
EHC
Encompass Health Corp
10.00B
find similar stocks of hims and hers
Intellectia · 208 candidates
Market Cap: 300.00M - 15.00BPs Ratio: <= 15.00Is Optionable: TrueAnnual Revenue Yoy Growth: >= 0.0%
Ticker
Name
Market Cap$
top bottom
GH logo
GH
Guardant Health Inc
14.98B
ICLR logo
ICLR
ICON PLC
14.12B
PEN logo
PEN
Penumbra Inc
14.03B
SOLV logo
SOLV
Solventum Corp
13.94B
SNN logo
SNN
Smith & Nephew PLC
13.91B
NBIX logo
NBIX
Neurocrine Biosciences Inc
13.50B
share the top 100 instead of 12
Intellectia · 24 candidates
Market Cap: >= 1000.00MNet Margin: >= 10.00Weekly Average Turnover: >= 1,000,000Pe Ttm: 17 - 23Return On Equity: >= 18.0%Annual Revenue Yoy Growth: >= 10.0%
Ticker
Name
Market Cap$
top bottom
NVS logo
NVS
Novartis AG
278.44B
COIN logo
COIN
Coinbase Global Inc
61.19B
AU logo
AU
Anglogold Ashanti PLC
51.18B
KGC logo
KGC
Kinross Gold Corp
43.05B
FUTU logo
FUTU
Futu Holdings Ltd
23.11B
FTI logo
FTI
TechnipFMC PLC
21.93B

Whales Holding EHC

O
Oberweis Asset Management, Inc.
Holding
EHC
+19.64%
3M Return
L
Leeward Investments, LLC
Holding
EHC
+16.69%
3M Return
F
Fuller & Thaler Asset Management, Inc.
Holding
EHC
+10.95%
3M Return
C
Copeland Capital Management, LLC
Holding
EHC
+7.74%
3M Return
S
Systematic Financial Management LP
Holding
EHC
+6.16%
3M Return
S
Scout Investments, Inc.
Holding
EHC
+5.22%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Encompass Health Corp (EHC) stock price today?

The current price of EHC is 104.12 USD — it has decreased -2.59

What is Encompass Health Corp (EHC)'s business?

Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. It operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. It operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. It provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.

What is the price predicton of EHC Stock?

Wall Street analysts forecast EHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EHC is146.75 USD with a low forecast of 134.00 USD and a high forecast of 160.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Encompass Health Corp (EHC)'s revenue for the last quarter?

Encompass Health Corp revenue for the last quarter amounts to 1.54B USD, increased 9.94

What is Encompass Health Corp (EHC)'s earnings per share (EPS) for the last quarter?

Encompass Health Corp. EPS for the last quarter amounts to 1.43 USD, increased 21.19

How many employees does Encompass Health Corp (EHC). have?

Encompass Health Corp (EHC) has 24611 emplpoyees as of March 11 2026.

What is Encompass Health Corp (EHC) market cap?

Today EHC has the market capitalization of 10.63B USD.